1. Medical Oncology, Dana-Farber Cancer Institute, and
2. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;
3. Bioinformatics and Computational Genomics Laboratory, Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada;
4. Department of Computing Science, University of Alberta, Edmonton, AB, Canada;
5. Dana-Farber Cancer Institute, Center for Cancer Systems Biology and Department of Genetics, Boston University School of Medicine, Boston University, Boston, MA;
6. Medical Oncology, University of Magna Græcia and Tommaso Campanella Cancer Center, Catanzaro, Italy;
7. Unité de Génomique du Myélome, Laboratoire Unité de Génomique du Myélome, University Hospital, Centre Hospitalier Universitaire Rangueil, Toulouse, France;
8. Hematology Laboratory, University Hospital, and INSERM U892, Nantes, France;
9. Molecular Diagnostics Laboratory, and
10. Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA;
11. Brigham and Women's Hospital, Boston, MA; and
12. Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA